Login / Signup

Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients.

Barbora WeinbergerováJiri MayerTomas KabutStepan HrabovskyJirina ProchazkovaZdenek KralVladimir HeroutRita PacasovaLenka Zdrazilova-DubskaPetr HusaPetr BednarDaniel RuzekMartina Lengerova
Published in: Hematological oncology (2021)
Keyphrases
  • end stage renal disease
  • ejection fraction
  • coronavirus disease
  • sars cov
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors